UNSPSC 51283611: Rifamycin sodium

This classification denotes an antitubercular agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 32086GS35Z. European Medicines Agency schedules Rifamycin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04246MIG. Rifamycin sodium generally arises in the molecular formula C37H46NO12.NA. The term 'rifamycin sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule rifamycin sodium under HS 29419000 and SITC 54139.

UNSPSC 51283611 Rifamycin sodium is a Commodity code that spans pharmaceutical manufacturing and supply, but recent state and local procurement activity under this code does not target rifamycin specifically. Instead, state and local governments are soliciting broader pharmaceutical and medical supply categories—generic multi-source pharmaceuticals, over-the-counter products, naloxone and drug deactivation systems, and emergency medical supplies—through centralized cooperative purchasing vehicles and individual agency procurements. The work involves supply agreements with manufacturers and distributors, compliance with Drug Supply Chain Security Act (DSCSA) and current Good Manufacturing Practices (cGMP) standards, and fulfillment through authorized wholesaler networks. Issuing bodies include state health and human services agencies, state cooperative purchasing alliances (MMCAP administered by the Minnesota Department of Administration), counties (Seminole County, Florida), and municipalities (City of Tampa).

Recent activity spans Minnesota, Florida, and Texas. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP on January 20, 2026, due March 26, 2026, seeking manufacturers to supply generic multi-source pharmaceuticals and OTC products through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with awards effective July 1, 2026 and contract terms of two years. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023. The City of Tampa issued IFB 26-P-00145 on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with a $700,000 estimated contract value and a 5% bid discount for certified Small Local Business Enterprises (SLBEs). The Texas Health and Human Services Commission released RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements.